Review: chemotherapy plus supportive care improves survival and quality of life in advanced or metastatic gastrointestinal cancer more than supportive care alone.
نویسنده
چکیده
Ahmed N, Ahmedzai S, Vora V, et al. Supportive care for patients with gastrointestinal cancer. Cochrane Database Syst Rev 2004;(3):CD003445. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Q Are cancer treatments that include supportive care (SC) more effective than SC alone for improving length of survival and quality of life in patients with advanced or metastatic gastrointestinal (GI) cancer?
منابع مشابه
Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.
OBJECTIVES To compare the length of survival and quality of life in patients given combination chemotherapy in addition to supportive care and in patients given only supportive care. DESIGN Randomised study. SETTING Gastrointestinal oncology departments. PATIENTS 40 previously untreated patients with histologically confirmed, measurable colorectal cancer that was locally recurrent or meta...
متن کاملDecision framework for chemotherapeutic interventions for metastatic non-small-cell lung cancer.
BACKGROUND Best supportive care has long been considered to be the standard therapy for metastatic non-small-cell lung cancer (NSCLC). There is now evidence from randomized trials that a number of chemotherapy regimens can palliate cancer-related symptoms and modestly improve survival. We show how cost-effectiveness analyses can be used to make choices between different (ambulatory) chemotherap...
متن کاملCost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer.
BACKGROUND Chemotherapy may relieve tumor-related symptoms, may improve quality of life and prolong survival in advanced gastrointestinal cancer. The extent of such improvements is unclear despite the extensive use of this treatment modality, and there are no studies concerning the economic cost of any gain achieved in the quantity and quality of life by chemotherapy. PATIENTS AND METHODS Bet...
متن کاملRandomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer.
BACKGROUND The extent to which chemotherapy may relieve tumour-related symptoms, improve quality of life and prolong survival in patients with gastric cancer is not known in spite of the extensive use of this treatment modality. The aim of this study was to estimate any gain in the quantity and quality of life produced by chemotherapy in these patients. PATIENTS AND METHODS Between January 19...
متن کاملChemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life.
BACKGROUND In 1995 a meta-analysis of randomised trials investigating the value of adding chemotherapy to primary treatment for non-small cell lung cancer (NSCLC) suggested a small survival benefit for cisplatin-based chemotherapy in each of the primary treatment settings. However, the meta-analysis included many small trials and trials with differing eligibility criteria and chemotherapy regim...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Evidence-based nursing
دوره 8 1 شماره
صفحات -
تاریخ انتشار 2005